|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.36 USD | +1.44% |
|
+2.58% | -3.64% |
ESSA Pharma Inc. announced that it has appointed Dr. David Parkinson to its board of directors. Dr. Parkinson's appointment as an independent director is effective immediately. David R. Parkinson is a Venture Partner at New Enterprise Associates.
From 2007 until 2012, Dr. Parkinson served as President and CEO of Nodality.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.64% | 278M | |
| +48.67% | 58.71B | |
| -2.76% | 41.31B | |
| +36.42% | 39.2B | |
| -11.22% | 27.4B | |
| +9.25% | 26.55B | |
| -23.10% | 18.98B | |
| +1.88% | 12.51B | |
| +26.43% | 12.08B | |
| +21.74% | 11.94B |
ESSA PHARMA INC. 
